Accumetrics Inc the first point-of-care method for measuring platelet reactivity, announces that its market-leading VerifyNow P2Y12 test was one of multiple methods evaluated in the POPular study presented during a Late Breaking Clinical Trials session at the American Heart Association’s annual Scientific Sessions.
Read MoreThat’s the question users of glucose monitors and other point-of-care (POC) tests may ask, according to a leading health care market research publisher.
Read More
Hospital-acquired infections exact a staggering toll.
Read MoreDiagnostic Hybrids announces FDA 510k clearance of its D3 FastPoint L-DFA Influenza A/ Influenza B Virus Identification Kit, which allows for the identification of influenza A virus and influenza B virus from a patients specimen in under 30 minutes.
Read MoreTyrian Diagnostics Limited announced today that Tyrian and BD will not continue their collaboration to develop a Point-of-Care (PoC) test for the diagnosis of active tuberculosis (TB).
Read More